Mifepristone may inhibit the midcycle gonadotropin surge at both ovarian and pituitary sites of action
The ability of mifepristone to delay ovulation is thought to be based on the antigonadotropic effects of the drug. In the current work, late–follicular phase administration of mifepristone resulted in decrease in both circulating FSH and inhibin B, suggesting both central and ovarian sites of action...
Saved in:
Published in | Fertility and sterility Vol. 84; no. 5; pp. 1545 - 1546 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Elsevier Inc
01.11.2005
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The ability of mifepristone to delay ovulation is thought to be based on the antigonadotropic effects of the drug. In the current work, late–follicular phase administration of mifepristone resulted in decrease in both circulating FSH and inhibin B, suggesting both central and ovarian sites of action. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0015-0282 1556-5653 |
DOI: | 10.1016/j.fertnstert.2005.04.058 |